Kerl, K., Ries, D., Unland, R., Borchert, C., Moreno, N., Hasselblatt, M., . . . Frühwald, M. (2013). The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells. BioMed Central.
Citação norma ChicagoKerl, Kornelius, et al. The Histone Deacetylase Inhibitor SAHA Acts in Synergism With Fenretinide and Doxorubicin to Control Growth of Rhabdoid Tumor Cells. BioMed Central, 2013.
ציטוט MLAKerl, Kornelius, et al. The Histone Deacetylase Inhibitor SAHA Acts in Synergism With Fenretinide and Doxorubicin to Control Growth of Rhabdoid Tumor Cells. BioMed Central, 2013.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.